George P. Christophi

Author

Washington University in St. Louis

Also Known As

G Christophi, G. P. Christophi, G.P. Christophi, George Christophi, George P Christophi, George P. Christophi

Publications

Citations

H-Index

Concepts

All Affiliations

Washington University in St. Louis SUNY Upstate Medical University Cedars-Sinai Medical Center Medical College of Wisconsin Albert Einstein College of Medicine

About

George P. Christophi is an author at Washington University in St. Louis specializing in medicine, immunology, and neuroimmunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	896
2	Cell Biology	6	6	435
3	Allergy	2	2	252
4	Cellular Physiology	2	2	222
5	Biochemistry	1	1	61

George P. Christophi

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
The microbial metabolite desaminotyrosine protects from influenza through type I interferon Ashley Steed, George P. Christophi, Gerard E. Kaiko, Science	2017	572
Induction of IL-33 expression and activity in central nervous system glia Chad A. Hudson, George P. Christophi, Ross C. Gruber, Journal of Leukocyte Biology ImmunologyImmune RegulationCell DeathCellular PhysiologyIl-33-producing Astrocytes	2008	205
Immune markers and differential signaling networks in ulcerative colitis and Crohnʼs disease George P. Christophi, Rong Rong, Philip G. Holtzapple, Inflammatory Bowel Diseases	2012	118
Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients George P. Christophi, Ross C. Gruber, Michael Panos, Clinical Immunology InflammationCytokineMultiple Sclerosis PatientsAutoimmune DiseaseInterleukin-33 Upregulation	2011	103
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis Parakkal Deepak, Quazim A. Alayo, Aava Khatiwada, Clinical Gastroenterology and Hepatology Clinical EpidemiologyGastroenterologyTherapeutic ControversyPharmacotherapyReal-world Cohort	2020	103
Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype George P. Christophi, Michael Panos, Chad A. Hudson, Laboratory Investigation InflammationCytokineMultiple Sclerosis PatientsInflammatory DiseaseAutoimmune Disease	2009	82
Ustekinumab Is Effective for the Treatment of Crohn’s Disease of the Pouch in a Multicenter Cohort Kimberly N. Weaver, Martin Gregory, Gaurav Syal, Inflammatory Bowel Diseases	2018	80
Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort Martin Gregory, Kimberly N. Weaver, Patrick Hoversten, Inflammatory Bowel Diseases	2019	76
SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients George P. Christophi, Chad A. Hudson, Ross C. Gruber, Laboratory Investigation CytokineMultiple Sclerosis PatientsAutoimmune DiseaseImmune Cell DevelopmentShp-1 Deficiency	2008	61
Temporal Regulation of the Bacterial Metabolite Deoxycholate during Colonic Repair Is Critical for Crypt Regeneration Umang Jain, Chin‐Wen Lai, Shanshan Xiong, Cell Host & Microbe Colonic RepairProbioticDysbiosisBiochemistryCrypt Regeneration	2018	61

Page 1